CBD Effects on Brain Development: Evidence, Mechanisms, and Guidance

Written & posted by Ingrid Ferris

CBD is everywhere these days, from oils and capsules to products marketed for sleep, stress, and everyday wellness. And as CBD use has become more common, researchers have started asking a bigger question: “How could CBD affect a brain that’s still developing?” 

It’s an important question because brain development doesn’t stop at birth or even childhood. The brain continues changing throughout adolescence and into young adulthood, refining the systems involved in memory, mood, decision-making, emotional regulation, and other cognitive processes.

CBD, or cannabidiol, is non-intoxicating, which means it doesn’t produce the “high” associated with THC. But that doesn’t mean CBD doesn’t affect the brain. It interacts with several biological systems involved in brain function, including the endocannabinoid system, which itself plays a role in neurodevelopment.

So far, though, there are more questions than definitive answers. Much of what we know about CBD effects on brain development comes from animal and lab research. Human studies are more limited, and research on cannabis or THC can’t automatically be used to draw conclusions about CBD alone. 

Below, we’ll look at what researchers currently know about CBD and the developing brain, from preclinical findings and pediatric clinical trials to prenatal exposure, potential mechanisms, 4safety considerations, and the biggest gaps that future studies still need to address.

Key Takeaways

• Research on CBD effects on brain development is still limited, particularly in humans.  Much of the developmental evidence comes from animal and laboratory studies.
• CBD and THC aren’t interchangeable. Research on marijuana or THC-containing cannabis products can’t automatically tell us what isolated CBD does to the developing brain.
• Timing, dose, duration of exposure, and age may all influence the effects of CBD, making it difficult to apply one study’s findings to every situation.
• Prescription CBD has been studied in children with certain seizure disorders, but those clinical trials don’t give us a complete picture of long-term brain development or cognitive changes.
• Until researchers know more, parents and clinicians should approach CBD use during pregnancy, childhood, and adolescence cautiously and consider the limits under current evidence.

Introduction to Cannabidiol (CBD) and Brain Development

CBD, or cannabidiol, is one of more than 100 cannabinoids found in the Cannabis sativa plant. Unlike tetrahydrocannabinol (THC), CBD isn’t intoxicating, but it can still influence signaling throughout the brain and central nervous system.

When we talk about CBD and brain development, we’re also talking about a much longer period than childhood alone. The human brain begins developing before birth and continues maturing through childhood, adolescence, and into young adulthood. Different brain regions and cognitive processes develop at different rates throughout that time.

That makes age an important part of the research. CBD exposure during pregnancy isn’t necessarily comparable to CBD use during childhood or adolescence, and findings from healthy volunteers or adults with specific health conditions can’t automatically tell us how CBD might affect a developing brain.

It’s also important to separate CBD-specific evidence from broader research on cannabis use. Cannabis products can contain THC, CBD, or other cannabinoids in widely varying amounts. Studies involving marijuana or THC-containing products can help researchers understand developmental risks associated with cannabis, but they don’t necessarily show what isolated CBD does. 

Throughout this article, we’ll make that distinction clear while looking at evidence from laboratory research, preclinical models, and human studies across different stages of development.

Biology Background: Endocannabinoid System and Brain Function

The endocannabinoid system (ECS) is a communication network found throughout the brain and body. It helps regulate everyday processes like mood, memory, sleep, stress, appetite, and pain, but its role begins well before adulthood.

During brain development, the ECS helps coordinate some of the processes that allow the nervous system to take shape. These include the formation of new neurons, the movement of developing neurons to the right location, the growth of connections between brain cells, and the refinement of the neural circuits that eventually support normal brain function.

Two of the system’s primary receptors are CB1 and CB2. CB1 receptors are especially abundant in the brain and central nervous system. Their location and activity change throughout development, and researchers have found them in developing neurons even before mature connections between those cells have formed. CB2 receptors are more closely associated with immune activity but are also found in the nervous system.

The body produces its own molecules, called endocannabinoids, that interact with these receptors and help regulate signaling. Cannabinoids from the cannabis plant can influence some of these pathways, although they don’t all act in the same way.

Because the ECS plays a crucial role during neurodevelopment, researchers are interested in whether exposure to outside cannabinoids could alter these carefully timed processes. That’s one reason the age, dose, and timing of CBD exposure matter when evaluating its potential effect on brain health.

Effects of CBD on Brain Development and Brain Health

Because long-term human studies are limited, much of what researchers currently know about CBD effects on brain development comes from preclinical research using animals and cells grown in a lab. 

So far, the findings aren’t entirely consistent. Some animal studies have found few harmful behavioral effects after CBD exposure, while others have reported changes involving memory, anxiety, brain structure, or signaling. Laboratory studies have also found that CBD can affect developing neurons and other brain cells under certain conditions.

One reason for these differences may be dose and timing. CBD exposure before birth, shortly after birth, or during adolescence occurs during very different stages of brain development. A single dose may also affect the brain differently from chronic CBD administration over days or weeks. The amount of CBD matters, too. In cellular research, some observed effects become more pronounced at higher concentrations.

Overall, preclinical evidence suggests that CBD is biologically active in the developing nervous system, but it doesn’t tell us that the same effects will occur in people. Animal doses, developmental timelines,  and laboratory concentrations don’t perfectly replicate human CBD use. That’s why these studies are best viewed as signals for further investigation rather than proof that CBD either harms or protects the developing human brain.

Animal Studies

Most animal research on CBD and brain development has been conducted in mice or rats, with researchers exposing animals during prenatal development, adolescence, or both, then measuring behavior and brain function later in life. Because of this, the results have been mixed.

In one study, mice received CBD twice daily throughout adolescence. When tested as adults, the CBD-treated mice showed no significant problems with locomotion, anxiety-like behavior, or spatial memory compared with the control group. They actually learned a spatial memory task somewhat faster, although female mice exposed to CBD gained less weight during treatment.

Other research has raised more questions. A 2025 study of chronic CBD administration during adolescence found lasting changes in locomotion, exploration, social behavior, and anxiety-like behavior in adult mice. Researchers also found that genetic differences affected how some animals responded to THC later in adulthood.

Prenatal exposure may produce different effects. Mouse studies have reported changes in problem-solving, pain sensitivity, and activity within the prefrontal cortex after CBD exposure during pregnancy. These findings suggest that the developmental window may be just as important as the dose itself.

Animal studies can also examine brain tissue in ways human studies can’t, giving researchers clues about changes in specific brain regions, neurotransmitter systems, and cognitive processes. 

However, a mouse isn’t a developing human. Differences in metabolism, dosing, routes of administration, and developmental timing make direct comparisons a little tricky. These studies help identify potential effects worth investigating, but ultimately, they can’t tell us with certainty what CBD exposure will do during human brain development.

Cellular and In Vitro Findings

Cell studies let researchers look more closely at what happens when individual brain cells are exposed directly to CBD.

Some experiments involving hippocampal neurons have found that CBD changes calcium signaling inside cells. Calcium helps neurons communicate and regulate essential processes, so researchers are interested in whether disrupting that balance could affect developing cells.

The effects appear to depend heavily on dose and cell type. In one study using neonatal rat brain cells, CBD exposure produced concentration- and time-dependent changes in neurons and astrocytes, including altered mitochondrial function and reduced cell viability. Other experiments using higher CBD concentrations have similarly found damage to neurons grown alone.

But the picture isn’t entirely negative. A neuron-astrocyte co-culture study found that astrocytes significantly reduced some of CBD’s harmful effects on neurons, including changes in calcium levels and mitochondrial function. Another study using a similar model found that CBD promoted growth and branching of developing neurons under specific laboratory conditions. 

These seemingly conflicting findings show why concentration matters. In vitro may expose cells directly to CBD at concentrations ranging from fractions of a micromolar to much higher levels, which isn’t the same as someone taking a CBD product and having it metabolized throughout the body.

For now, cellular research shows that CBD affects processes involved in neuronal development and function. It doesn’t establish that the same changes occur in the developing human brain, but it gives researchers specific mechanisms to investigate in future studies.

Clinical Trial Evidence: Cannabidiol, CBD Products, and Developmental Outcomes

Human research naturally gives us a better idea of how CBD affects children and adolescents, but there’s an important catch: most clinical trials weren’t designed specifically to study brain development. 

The strongest pediatric evidence comes from trials of prescription cannabidiol, including Epidolex, which is used to treat seizures associated with certain epilepsy disorders. Randomized clinical trials have included children as young as two and have shown that prescription CBD can reduce certain types of seizures. (You can also learn more about this in our article, “CBD for Seizures: Clear Guidance on Safe Daily Use.”)

Researchers have also studied CBD in children and adolescents with conditions such as autism and intellectual disability. Some trials have reported improvements in specific behavioral or anxiety measures, while others have found no significant differences between CBD and the control group on their primary outcomes.

But these studies leave a major gap. Measuring seizure frequency, anxiety, or behavior over several weeks or months isn’t the same as following cognition, executive function, memory, and other developmental outcomes for years. 

It’s also important not to apply findings from prescription CBD directly to over-the-counter CBD products. Clinical trials use carefully measured formulations and doses, while consumer products can vary in CBD concentration, purity, ingredients, and whether they contain THC or other cannabinoids.

So, human studies tell us considerably more about CBD’s short-term therapeutic effects and side effects in certain pediatric populations than they do about its long-term effects on the developing brain.

Pediatric and Adolescent Clinical Trials

Most pediatric CBD research has focused on specific health conditions rather than general brain development. The clearest example is prescription cannabidiol, or Epiolex, which has been tested in randomized clinical trials involving children and adolescents with severe seizure disorders.

In studies of conditions such as Dravet syndrome, participants as young as 2 received carefully measured doses of purified CBD alongside their usual medications. Researchers primarily tracked seizure frequency, safety, and adverse events rather than long-term changes in memory, executive function, or other developmental outcomes. 

CBD has also been studied in children with autism. A 2026 randomized, double-blind crossover trial followed 29 children ages 5 to 12 who received CBD oil or placebo for 12 weeks at a time. Researchers found no significant difference in the study’s primary measure of social responsiveness, although some secondary measures involving anxiety and social relating improved.

Another randomized clinical trial in autistic boys ages 7 to 14 tested purified CBD for eight weeks. Some behavioral measures improved during CBD treatment, but several comparisons between CBD and placebo weren’t statistically significant. 

These studies give researchers useful information about CBD treatment in pediatric populations, but they still don’t answer the larger developmental question. Short-term changes in seizures, anxiety, or behavior aren’t the same as measuring how repeated or chronic administration affects cognition, memory, brain structure, or development years later. 

That distinction is one of the biggest gaps in the current human evidence.

Pregnancy and Prenatal Exposure Studies

Pregnancy is one of the areas where the evidence gap around CBD is especially large.

Most human studies don’t isolate CBD exposure. Instead, they look at cannabis use during pregnancy, which may involve THC, CBD, and other cannabinoids in very different amounts. That makes it difficult to determine which compound is responsible for any observed effect.

Observational studies have linked prenatal cannabis exposure with outcomes such as lower birth weight or being small for gestational age, although findings on later developmental outcomes have been less consistent. Additionally, some studies have reported differences on early developmental screening, while others found weaker or no clear associations after accounting for factors such as tobacco use, alcohol use, socioeconomic conditions, and maternal mental health.

Those confounding factors matter. People who use cannabis during pregnancy may differ from non-users in many ways that can also affect pregnancy and child development, so an observational study can’t prove that cannabis directly caused a particular outcome.

Researchers have also started measuring THC and CBD exposure separately within cannabis-using groups. One recent cohort found lower birth-weight and length percentiles among cannabis-exposed newborns, but participants were exposed to substantially more THC than CBD, so the findings still can’t be interpreted as evidence of a CBD-specific effect.

For isolated CBD, the human data remain extremely limited. Because of that uncertainty and concerns raised by animal studies, the FDA currently advises against using CBD, THC, or marijuana during pregnancy or breastfeeding.

The clearest takeaway? Prenatal cannabis research shouldn’t be presented as direct evidence about CBD alone.

Cannabis Use, Medical Marijuana, and Developmental Risk

CBD may come from the cannabis plant, but using isolated CBD isn’t the same as using marijuana. Most marijuana contains tetrahydrocannabinol (THC), the intoxicating cannabinoid responsible for the “high.” THC directly affects brain function, including areas involved in memory, learning, attention, decision-making, and coordination. These effects are especially relevant during adolescence, when the brain is still developing. 

Research reviewed by the National Academies has found evidence that recent cannabis use can temporarily impair learning, memory, and attention. However, the evidence surrounding persistent cognitive effects is less clear, and factors such as age of first use, THC potency, genetics, and use of alcohol or other substances can make the long-term effects difficult to interpret.

That same distinction applies to medical marijuana. A cannabis product sold or recommended for medical purposes may contain THC, CBD, or both. That’s very different from purified cannabidiol used in a controlled clinical trial. Product potency and cannabinoid content can also vary, particularly because state-regulated cannabis products don’t follow the same federal approval process as prescription medications.

For adolescents in particular, researchers remain concerned about frequent or heavy cannabis use during a period of active brain development. A systematic review found a small association between frequent cannabis use and reduced cognitive functioning in adolescents and young adults, although those differences were substantially smaller in studies requiring more than 72 hours of abstinence. 

The takeaway isn’t that cannabis research proves CBD harms brain development. Instead, THC exposure, isolated CBD, and mixed cannabis products need to be evaluated separately when discussing developmental risk.

How CBD Interacts with the Endocannabinoid System and Brain Function

CBD’s effects on the brain are complicated because it doesn’t work through a single receptor or pathway. Unlike THC, CBD doesn’t strongly activate CB1 receptors. Lab research suggests CBD can act as a negative allosteric modulator of CB1, meaning it may change how the receptor responds to other compounds that activate it rather than switching the receptor on itself.

But the endocannabinoid system is only part of the picture. CBD interacts with several other molecular targets involved in brain function, including serotonin 5-HT1A receptors and TRPV1 channels. Researchers are also investigating how CBD affects signaling involving GABA and glutamate, two neurotransmitters that play major roles in controlling communication between brain cells.

These pathways may help explain some of CBD’s observed effects on anxiety, stress, inflammation, and seizure activity. CBD has also demonstrated anti-inflammatory and antioxidant activity in preclinical models, which has generated interest in whether it could influence brain health under certain conditions.

However, a possible mechanism isn’t the same as a proven developmental benefit. Much of this research comes from cells and animals, and the effects can vary depending on dose, brain region, cell type, and experimental conditions. That’s especially important when discussing a developing brain. 

The same signaling systems CBD affects are involved in processes such as neuronal growth, communication, and neural circuit formation. Researchers still need more human studies to fully understand whether altering those pathways with CBD during different developmental stages produces meaningful long-term effects.

Safety, Dosing, and CBD Products Considerations

CBD comes in many forms, including oils, capsules, gummies, topicals, and prescription cannabidiol. How much CBD reaches the bloodstream can vary based on the dose, formulation, route of administration, food intake, and individual metabolism.

That’s one reason there isn’t a universal CBD dose for brain health, especially not for children or adolescents. The high doses used in some clinical trials also shouldn’t be treated as dosing recommendations for over-the-counter products.

Drug interactions are another important consideration. CBD can affect the way the body processes other medications, potentially changing their effects or side effects. Research on prescription CBD has also identified risks such as sleepiness and liver enzyme elevations.

Product quality matters, too. Unlike prescription cannabidiol, over-the-counter CBD products aren’t FDA-approved medications, and testing has found that some commercially available products contain different amounts of CBD than their labels claim. THC or contaminants may also be present in some products.

For children, adolescents, and anyone taking medicines, CBD use is something to discuss with a qualified healthcare provider rather than approach through trial and error. And during pregnancy or breastfeeding, the FDA currently recommends avoiding CBD because its developmental effects aren’t well understood.

If a healthcare professional has approved CBD for your situation, choosing a transparent, well-tested product matters. At Myriam’s Hemp, we provide third-party lab results for our hemp products, making it easy to check cannabinoid content and testing information before adding a product to your routine.

Research Gaps and Future Clinical Trial Priorities

The biggest gap in CBD research isn’t another short-term study; it’s understanding what happens over time.

Future studies need to follow children and adolescents long enough to measure developmental outcomes such as memory, attention, executive function, emotional regulation, and other aspects of cognition. Researchers also need age-specific clinical trials, since CBD exposure during early childhood may not have the same effects as exposure during adolescence or young adulthood.

Neuroimaging studies could add another piece to the puzzle by showing whether CBD is associated with measurable changes in brain structure, activity, or connectivity. Biomarkers could similarly help researchers understand what’s happening biologically alongside any observed behavioral changes.

Finally, studies need more consistent doses, product formulations, outcome measures, and reporting standards. Long-term follow-up will be especially important for determining whether any observed effects are temporary, persistent, beneficial, harmful, or simply unrelated to CBD.

Until those studies exist, current findings can point researchers in useful directions, but they can’t give us a complete picture of CBD’s long-term effects on brain development.

What We Know About CBD and Brain Development

Research into CBD effects on brain development is still evolving. Preclinical studies show that CBD can influence processes involved in brain function, but animal and cellular findings don’t automatically translate to humans. Clinical trials give us useful safety and treatment data in certain pediatric populations, yet we still know relatively little about the long-term effects of CBD exposure on memory, cognition, executive function, and overall brain health.

If you and your healthcare provider have determined that CBD is appropriate for your situation, Myriam’s Hemp offers a range of lab-tested hemp products made with a focus on quality and transparency. Explore our CBD products to find an option that fits your needs, and always speak with your healthcare provider about CBD use during pregnancy, childhood, adolescence, or alongside other medications.